Ideaya Biosciences

IPO

Improving lives through transformative precision medicines

Public · South San Francisco, United States · Founded 2015

Employees
201–500
Founded
2015
Business Model
B2B
Type
Public

About

IDEAYA Biosciences is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. The company targets hidden tumor vulnerabilities through synthetic lethality, metabolic and epigenetic dependencies, and other precision oncology approaches designed to overcome tumor growth and drug resistance. Its pipeline includes PKC inhibition in uveal melanoma, TOP1 ADC and DNA-damage-response combinations, MTAP-pathway programs for MTAP-deleted cancers, and KAT6/7 epigenetic inhibitors, with clinical trials focused on patients who have limited treatment options.

Summary

Ideaya Biosciences is a Biotech company based in South San Francisco, United States, founded in 2015.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Mirador Therapeutics

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego, United States11–50Biotech, Drug Discovery
Series BTotal funding$650.0MOct 2025
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ideaya Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/ideaya-biosciences"><img src="https://indexed.vc/api/badge/company/ideaya-biosciences" alt="Ideaya Biosciences on Indexed.vc" width="260" height="76" /></a>